Capgemini Life Sciences and Healthcare

🌟 Join Us at Dreamforce 2024! 🌟 We are excited to announce that later this month, our team will be heading to San Francisco for #Dreamforce 2024. We are thrilled to host an exclusive session in the MOMA Atrium on September 17th: “Bring your Healthcare Professional (HCP) and Patient Experience to the Next Level with Salesforce.” In this session, Thorsten Alexander Rall Bibin Viyyath will explore how to deliver the best possible customer experiences through transformative technology. Drawing from our extensive experience in the Life Sciences industry, we will share insights on leveraging the Salesforce platform to revolutionize customer experience (CX) and meet the evolving expectations of HCPs and patients. Highlights of the session include: - Strategies to navigate changes in the Life Sciences market - A hands-on Salesforce demonstration showcasing improvements in disease management and treatment orchestration - Boosting HCP initiatives and patient engagement After the session, Thorsten Alexander Rall and Bibin Viyyath will be available to connect, answer your questions, and discuss how, together with Salesforce, we can transform patient outcomes and meet rising HCP and patient expectations. 📅 Date: September 17th 🕒 Time: 3:00 p.m. - 3:30 p.m. PST 📍 Location: MOMA Atrium (151 3rd St.), San Francisco Don’t miss this opportunity to connect with forward-thinking industry peers and learn more about the transformative power of Salesforce. Register now for our exclusive session: https://lnkd.in/dYcyXdzm For those attending Dreamforce, visit us at the Capgemini booth No. 1400 at the Moscone Center. We look forward to seeing you there! #Salesforce #Capgemini #Dreamforce2024 #LifeSciences #CustomerExperience #Healthcare

🌟 Get ready to witness the future of pharma and healthcare at BioTechX Europe 2024! 🌟 We’re beyond excited to be part of this groundbreaking event in Basel, Europe’s pharma hub, on October 9 and 10. Join us as we showcase our expertise in R&D, Clinical Development, GenAI, and pharma innovation. With 3,500+ attendees, 400+ speakers, and 50+ start-ups, this is THE go-to event for diagnostics, precision medicine, and digital transformation in pharma. Get ready for unparalleled networking opportunities and insights from top pharmaceutical and biotech companies. Explore the future with us - visit the link to find out more! https://lnkd.in/dGcQqSQd #BioTechX #PharmaInnovation #DigitalTransformation #Healthcare #ExploreTheFuture

📈 Organizations today are more efficient at integrating data and insights into core business processes. 📊 65% of the business executives we surveyed said that their CxOs use insights taken from data to steer business decisions. Organizations that lead the way in harnessing data insights outperform their counterparts across various metrics, including: ➡️ Quality ➡️ Security ➡️ Monetization To find out more about how generative AI is impacting #DataOperations, download the full report https://bit.ly/3XeowBk #GenAI #Pharma #Medtech

#DigitalHealth solutions, such as telemedicine platforms, clinical decision-support systems, and monitoring devices, have emerged as top priorities in the #healthcare sector. With over 60% of organizations currently offering or planning to integrate these technologies into their portfolios, the #MedTech industry's commitment to #ConnectedHealth is evident. Grab a copy of our report for a complete picture of this: https://bit.ly/3z3ofaF

Revolutionizing Pharmaceuticals with Trustworthy AI We’re leading the way in integrating trustworthy AI into the life sciences sector. Our innovative approach ensures that AI solutions are both cutting-edge and safe, ethical, and compliant with the latest regulations. From accelerating drug discovery to enhancing clinical trials, we’re transforming the pharmaceutical industry with responsible AI. Our latest POV series explores what it takes to integrate, master, and comply with trusted AI in life sciences. You don't want to miss out on this game-changing insight! Ready to learn more? Check out our full POV here: https://lnkd.in/gFqYcQqq #AI #Pharma #HealthcareInnovation #TrustworthyAI #FutureOfMedicine

Innovation brings opportunity. But just as often, it introduces complexity.   For life sciences organizations, that is certainly the case. Cell and gene therapies, digital therapeutics, personalized medicine, and biomarkers, and the integration of drugs and medical devices have sparked incredible advancements for the industry, but they have also created new challenges when it comes to clinical trials.   Check out our POV and discover more https://bit.ly/4aXOvSl 

🔍 The connected health revolution is reshaping the healthcare landscape, and life sciences organizations are at the forefront of this transformation. As Thorsten Alexander Rall already mentions in the video, these are some of the highlights from the CRI Report #connectedhealthresearch Market Adoption: A remarkable 63% of life sciences organizations already have connected health products on the market or in development. Biopharma companies have seen a sixfold increase in connected health offerings since 2021. Revenue Impact: By 2028, organizations anticipate that connected health will contribute an average of 22% to their total revenue. This shift is driven by digital health solutions like telemedicine platforms, clinical decision-support systems, and wearables. AI Potential: Generative AI technologies offer significant benefits, including improved patient support, personalized care, and operational efficiency. Challenges: To fully harness connected health’s potential, organizations must address strategy, governance, funding, technology integration, data management, regulations, and talent. If you want to know more, download the full report here: https://bit.ly/3z3ofaF #ConnectedHealth #HealthcareInnovation #DigitalHealth

💥 Join 200+ global experts for an exclusive event to discover the future of MES. Learn from real-world case studies and leave with game-changing strategies to revolutionize your operations. Secure your spot now and stay ahead of the curve in innovation! http://bit.ly/3WcKRyV #PharmaMESBerlin #Agility #Intelligence #Capgemini

At Capgemini, we’re all data geeks, we're all about transforming data and research into real results, pushing pharma and healthcare into the future. That’s why we’re thrilled to be part of BioTechX Europe 2024, showcasing our R&D, Clinical Development, GenAI, and pharma innovation capabilities and expertise. If you wonder what’s BioTechX Europe.... is the go-to event for diagnostics, precision medicine, and digital transformation in pharma and healthcare. This year, it’s back in Basel, Europe’s pharma hub, with 3500 global execs, 400 speakers, and 50 start-ups all under one roof. The event is packed with networking opportunities and insights from top pharmaceutical and biotech companies, healthcare systems providers, and academic groups....and us of course :-). Join Our expert-led panel discussions at BioTechX, we will be moderating a series of panel discussions on critical topics such as data integration, FAIR (Findable, Accessible, Interoperable, and Reusable) data principles, and digital transformation. These discussions will feature industry leaders and experts, providing valuable insights and fostering collaboration in the biotech community. Join us as we explore these pivotal areas and contribute to the advancement of biotechnology. Making a splash Long story short, we’re not just attending—we’re making a splash. Capgemini will have a booth and we will be on stage, showing we mean business. We’re excited to share our deep industry knowledge and innovative solutions in pharma. Plus, we’ve got some exciting content for you to download before the event—a little pre-event joy to get you pumped! Join us at BioTechX Europe 2024 in Basel and be part of the future of biotech and pharma. Want to know more? You can find the full agenda here: https://lnkd.in/gHvAR2qS

🚀 Executives report a surge in using activated data for innovation, with two-thirds now leveraging it for new products or services. Our latest report takes insights from 500 business executives and 500 data executives to explore the rise of #generativeAI and its impact on data operations. Discover how Gen AI is reshaping #DataOperations and unlocking new opportunities. Download the full report here. https://bit.ly/3XeowBk